Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study

Abstract Introduction Many immunization programs in Europe recommend quadrivalent meningococcal vaccinations, which are often administered concomitantly with other vaccines. We compared the immune response of a tetanus toxoid conjugated quadrivalent meningococcal vaccine (MenACYW-TT, MenQuadfi®) wit...

Full description

Bibliographic Details
Main Authors: Javier Díez-Domingo, Róbert Simkó, Giancarlo Icardi, Chan Poh Chong, Céline Zocchetti, Olga Syrkina, Siham Bchir, Isabelle Bertrand-Gerentes
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-07-01
Series:Infectious Diseases and Therapy
Subjects:
Invasive meningococcal disease
Vaccination
Immunogenicity
Safety
MenACYW-TT
MCV4-TT
Online Access:https://doi.org/10.1007/s40121-024-01009-x

Internet

https://doi.org/10.1007/s40121-024-01009-x

Similar Items